Overexpression of the VSSC-associated CAM, beta-2, enhances LNCaP cell metastasis associated behavior

Prostate

Volumn 72, Issue 10, 2012, Pages 1080-1092

  Jansson, Keith H ^a   Lynch, Jill E ^a   Lepori Bui, Nadia ^a   Czymmek, Kirk J ^a   Duncan, Randall L ^a   Sikes, Robert A ^a  

^a UNIVERSITY OF DELAWARE   (United States)

Author keywords

auxiliary subunit; C4 2B; castrate resistant; LNCaP; motility; neoplasm; prostate; sodium channel; voltage gated; voltage sensitive

Indexed keywords

ANDROGEN; CELL ADHESION MOLECULE; CYAN FLUORESCENT PROTEIN; PROTEIN; SODIUM CHANNEL SUBUNIT BETA 2; UNCLASSIFIED DRUG; VITRONECTIN; VOLTAGE GATED SODIUM CHANNEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER LOCALIZATION; CELL ADHESION; CELL MEMBRANE; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL STRAIN LNCAP; CELL STRUCTURE; CELL VIABILITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; IN VITRO STUDY; IN VIVO STUDY; MALE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; TUMOR VOLUME; WOUND HEALING;

ANIMALS; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CELL MOVEMENT; EPITHELIAL SODIUM CHANNEL; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; PROSTATIC NEOPLASMS; PROTEIN SUBUNITS; SODIUM CHANNELS; UP-REGULATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84859733307     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21512     Document Type: Article

References (62)

1. Walsh PC, Worthington JF,. Dr. Patrick Walsh's guide to surviving prostate cancer. New York: Warner Books; 2002. pp. xvi, 462.
2. Jemal A, Center MM, Ward E, Thun MJ,. Cancer occurrence. Methods Mol Biol 2009; 471: 3-29.
3. Carlin BI, Andriole GL,. The natural history, skeletal complications, and management of bone metastases in patients with prostate carcinoma. Cancer 2000; 88 (12 Suppl): 2989-2994.
4. Hellerstedt BA, Pienta KJ,. The current state of hormonal therapy for prostate cancer. CA Cancer J Clin 2002; 52 (3): 154-179.
5. Edlund M, Miyamoto T, Sikes RA, Ogle R, Laurie GW, Farach-Carson MC, Otey CA, Zhau HE, Chung LW,. Integrin expression and usage by prostate cancer cell lines on laminin substrata. Cell Growth Differ 2001; 12 (2): 99-107.
6. Koeneman KS, Yeung F, Chung LW,. Osteomimetic properties of prostate cancer cells: A hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment. Prostate 1999; 39 (4): 246-261.
7. Chioni AM, Brackenbury WJ, Calhoun JD, Isom LL, Djamgoz MB,. A novel adhesion molecule in human breast cancer cells: Voltage-gated Na+ channel beta1 subunit. Int J Biochem Cell Biol 2009; 41 (5): 1216-1227.
8. Diss JK, Fraser SP, Djamgoz MB,. Voltage-gated Na+ channels: Multiplicity of expression, plasticity, functional implications and pathophysiological aspects. Eur Biophys J 2004; 33 (3): 180-193.
9. Brackenbury WJ, Djamgoz MB, Isom LL,. An emerging role for voltage-gated Na+ channels in cellular migration: Regulation of central nervous system development and potentiation of invasive cancers. Neuroscientist 2008; 14 (6): 571-583.
10. Brackenbury WJ, Chioni AM, Diss JK, Djamgoz MB,. The neonatal splice variant of Nav1.5 potentiates in vitro invasive behaviour of MDA-MB-231 human breast cancer cells. Breast Cancer Res Treat 2007; 101 (2): 149-160.
11. Diss JK, Fraser SP, Walker MM, Patel A, Latchman DS, Djamgoz MB,. Beta-subunits of voltage-gated sodium channels in human prostate cancer: Quantitative in vitro and in vivo analyses of mRNA expression. Prostate Cancer Prostatic Dis 2008; 11 (4): 325-333.
12. Sikes RA, Walls AM, Brennen WN, Anderson JD, Choudhury-Mukherjee I, Schenck HA, Brown ML,. Therapeutic approaches targeting prostate cancer progression using novel voltage-gated ion channel blockers. Clin Prostate Cancer 2003; 2 (3): 181-187.
13. Anderson JD, Hansen TP, Lenkowski PW, Walls AM, Choudhury IM, Schenck HA, Friehling M, Holl GM, Patel MK, Sikes RA, Brown ML,. Voltage-gated sodium channel blockers as cytostatic inhibitors of the androgen-independent prostate cancer cell line PC-3. Mol Cancer Ther 2003; 2 (11): 1149-1154.
14. Grimes JA, Djamgoz MB,. Electrophysiological characterization of voltage-gated Na+ current expressed in the highly metastatic Mat-LyLu cell line of rat prostate cancer. J Cell Physiol 1998; 175 (1): 50-58.
15. Fraser SP, Salvador V, Manning EA, Mizal J, Altun S, Raza M, Berridge RJ, Djamgoz MB,. Contribution of functional voltage-gated Na+ channel expression to cell behaviors involved in the metastatic cascade in rat prostate cancer: I. Lateral motility. J Cell Physiol 2003; 195 (3): 479-487.
16. Catterall WA,. From ionic currents to molecular mechanisms: The structure and function of voltage-gated sodium channels. Neuron 2000; 26 (1): 13-25.
17. Wood JN, Boorman JP, Okuse K, Baker MD,. Voltage-gated sodium channels and pain pathways. J Neurobiol 2004; 61 (1): 55-71.
18. Catterall WA, Goldin AL, Waxman SG,. International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacol Rev 2005; 57 (4): 397-409.
19. Mulley JC, Scheffer IE, Petrou S, Berkovic SF,. Channelopathies as a genetic cause of epilepsy. Curr Opin Neurol 2003; 16 (2): 171-176.
20. Rhodes TH, Lossin C, Vanoye CG, Wang DW, George AL Jr., Noninactivating voltage-gated sodium channels in severe myoclonic epilepsy of infancy. Proc Natl Acad Sci USA 2004; 101 (30): 11147-11152.
21. Watanabe H, Darbar D, Kaiser DW, Jiramongkolchai K, Chopra S, Donahue BS, Kannankeril PJ, Roden DM,. Mutations in sodium channel beta1- and beta2-subunits associated with atrial fibrillation. Circ Arrhythm Electrophysiol 2009; 2 (3): 268-275.
22. Catterall WA,. Cellular and molecular biology of voltage-gated sodium channels. Physiol Rev 1992; 72 (4 Suppl): S15-S48.
23. Meadows L, Malhotra JD, Stetzer A, Isom LL, Ragsdale DS,. The intracellular segment of the sodium channel beta 1 subunit is required for its efficient association with the channel alpha subunit. J Neurochem 2001; 76 (6): 1871-1878.
24. Aman TK, Grieco-Calub TM, Chen C, Rusconi R, Slat EA, Isom LL, Raman IM,. Regulation of persistent Na current by interactions between beta subunits of voltage-gated Na channels. J Neurosci 2009; 29 (7): 2027-2042.
25. Grieco TM, Malhotra JD, Chen C, Isom LL, Raman IM,. Open-channel block by the cytoplasmic tail of sodium channel beta4 as a mechanism for resurgent sodium current. Neuron 2005; 45 (2): 233-244.
26. Yu FH, Westenbroek RE, Silos-Santiago I, McCormick KA, Lawson D, Ge P, Ferriera H, Lilly J, DiStefano PS, Catterall WA, Scheuer T, Curtis R,. Sodium channel beta4, a new disulfide-linked auxiliary subunit with similarity to beta2. J Neurosci 2003; 23 (20): 7577-7585.
27. Patton DE, Isom LL, Catterall WA, Goldin AL,. The adult rat brain beta 1 subunit modifies activation and inactivation gating of multiple sodium channel alpha subunits. J Biol Chem 1994; 269 (26): 17649-17655.
28. Srinivasan J, Schachner M, Catterall WA,. Interaction of voltage-gated sodium channels with the extracellular matrix molecules Tenascin-C and Tenascin-R. Proc Natl Acad Sci USA 1998; 95 (26): 15753-15757.
29. Xiao ZC, Ragsdale DS, Malhotra JD, Mattei LN, Braun PE, Schachner M, Isom LL,. Tenascin-R is a functional modulator of sodium channel beta subunits. J Biol Chem 1999; 274 (37): 26511-26517.
30. McEwen DP, Meadows LS, Chen C, Thyagarajan V, Isom LL,. Sodium channel beta1 subunit-mediated modulation of Nav1.2 currents and cell surface density is dependent on interactions with contactin and ankyrin. J Biol Chem 2004; 279 (16): 16044-16049.
31. Kazarinova-Noyes K, Malhotra JD, McEwen DP, Mattei LN, Berglund EO, Ranscht B, Levinson SR, Schachner M, Shrager P, Isom LL, Xiao ZC,. Contactin associates with Na+ channels and increases their functional expression. J Neurosci 2001; 21 (19): 7517-7525.
32. Huth T, Schmidt-Neuenfeldt K, Rittger A, Saftig P, Reiss K, Alzheimer C,. Non-proteolytic effect of beta-site APP-cleaving enzyme 1 (BACE1) on sodium channel function. Neurobiol Dis 2009; 33 (2): 282-289.
33. Kim DY, Ingano LA, Carey BW, Pettingell WH, Kovacs DM,. Presenilin/gamma-secretase-mediated cleavage of the voltage-gated sodium channel beta2-subunit regulates cell adhesion and migration. J Biol Chem 2005; 280 (24): 23251-23261.
34. Kim DY, Carey BW, Wang H, Ingano LA, Binshtok AM, Wertz MH, Pettingell WH, He P, Lee VM, Woolf CJ, Kovacs DM,. BACE1 regulates voltage-gated sodium channels and neuronal activity. Nat Cell Biol 2007; 9 (7): 755-764.
35. Malhotra JD, Kazen-Gillespie K, Hortsch M, Isom LL,. Sodium channel beta subunits mediate homophilic cell adhesion and recruit ankyrin to points of cell-cell contact. J Biol Chem 2000; 275 (15): 11383-11388.
36. Isom LL,. The role of sodium channels in cell adhesion. Front Biosci 2002; 7: 12-23.
37. Isom LL, Ragsdale DS, De Jongh KS, Westenbroek RE, Reber BF, Scheuer T, Catterall WA,. Structure and function of the beta 2 subunit of brain sodium channels, a transmembrane glycoprotein with a CAM motif. Cell 1995; 83 (3): 433-442.
38. Chen C, Bharucha V, Chen Y, Westenbroek RE, Brown A, Malhotra JD, Jones D, Avery C, Gillespie PJ III, Kazen-Gillespie KA, Kazarinova-Noyes K, Shrager P, Saunders TL, Macdonald RL, Ransom BR, Scheuer T, Catterall WA, Isom LL,. Reduced sodium channel density, altered voltage dependence of inactivation, and increased susceptibility to seizures in mice lacking sodium channel beta 2-subunits. Proc Natl Acad Sci USA 2002; 99 (26): 17072-17077.
39. Horoszewicz JS, Leong SS, Chu TM, Wajsman ZL, Friedman M, Papsidero L, Kim U, Chai LS, Kakati S, Arya SK, Sandberg AA,. The LNCaP cell line - A new model for studies on human prostatic carcinoma. Prog Clin Biol Res 1980; 37: 115-132.
40. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA, Murphy GP,. LNCaP model of human prostatic carcinoma. Cancer Res 1983; 43 (4): 1809-1818.
41. Thalmann GN, Anezinis PE, Chang SM, Zhau HE, Kim EE, Hopwood VL, Pathak S, von Eschenbach AC, Chung LW,. Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. Cancer Res 1994; 54 (10): 2577-2581.
42. Thalmann GN, Sikes RA, Wu TT, Degeorges A, Chang SM, Ozen M, Pathak S, Chung LW,. LNCaP progression model of human prostate cancer: Androgen-independence and osseous metastasis. Prostate 2000; 44 (2): 91-103 Jul 101;144(102).
43. Chang SM, Chung LW,. Interaction between prostatic fibroblast and epithelial cells in culture: Role of androgen. Endocrinology 1989; 125 (5): 2719-2727.
44. Sambrook J, Russell DW,. Molecular cloning: A laboratory manual. 3rd edition. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 2001.
45. Gillies RJ, Didier N, Denton M,. Determination of cell number in monolayer cultures. Anal Biochem 1986; 159 (1): 109-113.
46. Sikes RA, Chung LW,. Acquisition of a tumorigenic phenotype by a rat ventral prostate epithelial cell line expressing a transfected activated neu oncogene. Cancer Res 1992; 52 (11): 3174-3181.
47. Lynch JE, Allen SM, Jones PA, Fiske JL, Sikes RA,. Proceedings American Association of Cancer Research, Annual Meeting 2007 in Los Angeles, California. Abstract # 3949.
48. Krueckl SL, Sikes RA, Edlund NM, Bell RH, Hurtado-Coll A, Fazli L, Gleave ME, Cox ME,. Increased insulin-like growth factor I receptor expression and signaling are components of androgen-independent progression in a lineage-derived prostate cancer progression model. Cancer Res 2004; 64 (23): 8620-8629.
49. Balk SP, Knudsen KE,. AR, the cell cycle, and prostate cancer. Nucl Recept Signal 2008; 6: e001.
50. Heemers HV, Tindall DJ,. Unraveling the complexities of androgen receptor signaling in prostate cancer cells. Cancer Cell 2009; 15 (4): 245-247.
51. Hazan RB, Phillips GR, Qiao RF, Norton L, Aaronson SA,. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol 2000; 148 (4): 779-790.
52. Nieman MT, Prudoff RS, Johnson KR, Wheelock MJ,. N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol 1999; 147 (3): 631-644.
53. Gravdal K, Halvorsen OJ, Haukaas SA, Akslen LA,. A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer. Clin Cancer Res 2007; 13 (23): 7003-7011.
54. Jaggi M, Nazemi T, Abrahams NA, Baker JJ, Galich A, Smith LM, Balaji KC,. N-cadherin switching occurs in high Gleason grade prostate cancer. Prostate 2006; 66 (2): 193-199.
55. Weidle UH, Eggle D, Klostermann S,. L1-CAM as a target for treatment of cancer with monoclonal antibodies. Anticancer Res 2009; 29 (12): 4919-4931.
56. Banks RE, Gearing AJ, Hemingway IK, Norfolk DR, Perren TJ, Selby PJ,. Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies. Br J Cancer 1993; 68 (1): 122-124.
57. Natali P, Nicotra MR, Cavaliere R, Bigotti A, Romano G, Temponi M, Ferrone S,. Differential expression of intercellular adhesion molecule 1 in primary and metastatic melanoma lesions. Cancer Res 1990; 50 (4): 1271-1278.
58. Gao R, Shen Y, Cai J, Lei M, Wang Z,. Expression of voltage-gated sodium channel alpha subunit in human ovarian cancer. Oncol Rep 2010; 23 (5): 1293-1299.
59. Tamariz E, Grinnell F,. Modulation of fibroblast morphology and adhesion during collagen matrix remodeling. Mol Biol Cell 2002; 13 (11): 3915-3929.
60. Harvey P, Warn A, Dobbin S, Arakaki N, Daikuhara Y, Jaurand MC, Warn RM,. Expression of HGF/SF in mesothelioma cell lines and its effects on cell motility, proliferation and morphology. Br J Cancer 1998; 77 (7): 1052-1059.
61. Hasanuzzaman M, Kutner R, Agha-Mohammadi S, Reiser J, Sehgal I,. A doxycycline-inducible urokinase receptor (uPAR) upregulates uPAR activities including resistance to anoikis in human prostate cancer cell lines. Mol Cancer 2007; 6: 34.
62. Sequeira L, Dubyk CW, Riesenberger TA, Cooper CR, van Golen KL,. Rho GTPases in PC-3 prostate cancer cell morphology, invasion and tumor cell diapedesis. Clin Exp Metastasis 2008; 25 (5): 569-579.